WilmerHale represented Thermo Fisher Scientific Inc., the world leader in serving science, in connection with its recent public offering of $700.0 million aggregate principal amount of 1.750% Senior Notes due 2028, $1.2 billion aggregate principal amount of 2.000% Senior Notes due 2031 and $1.2 billion aggregate principal amount of 2.800% Senior Notes due 2041. Net proceeds from the offering will be used to pay a portion of the cash consideration payable for Thermo Fisher’s previously announced pending acquisition of PPD, Inc. The transaction closed on August 23, 2021.
The WilmerHale team representing Thermo Fisher was led by corporate partners Erika Robinson and Justin Ochs, counsel Andrew Langworthy, and senior associate Ryan S. Brewer, and included partner Julie Hogan Rodgers and counsel Seth Davis.
For more information, read Thermo Fisher’s press release.